Georgia's life sciences companies could gain about $300 million during the next 10 years from licensing agreements, strategic partnerships and fundraising as the state hosts this year's BIO International Convention in Atlanta, said Georgia Bio CEO Charles Craig. Atlanta's infrastructure and compatibility with BIO's strategy to drive the event around the U.S. are the reasons why the trade group chose the city over Raleigh, N.C., said Jim Greenwood, BIO's president and CEO.

Related Summaries